The drug targets of breast cancer, including ER, AR and human epidermal growth factor receptor 2 were successfully detected from CTC, and the full transcriptome analysis of CTCs was effectively realised to study the heterogeneity of tumor cells further. This evidence concerns the gene ESR1 and breast cancer.